Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Balance Sheet 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 1.47B | 1.45B | 653.7M | 701.3M | 610.3M | 298.6M |
| Cash & Equivalents | 743.3M | 594.4M | 391.6M | 549.9M | 285.1M | 262.1M |
| Liabilities | ||||||
| Total Liabilities | 343.3M | 413.8M | 190.3M | 215.5M | 67.4M | 56.6M |
| Long-Term Debt | — | — | — | — | 723,000 | — |
| Equity | ||||||
| Shareholders' Equity | 1.13B | 1.03B | 463.4M | 485.8M | 542.9M | -206.3M |
Recursion Pharmaceuticals, Inc. Balance Sheet — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) balance sheet over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's balance sheet history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s balance sheet by year and by quarter, including the growth rate.